DK1017408T3 - Anvendelse af tetrahydrolipstatin i behandling af diabetes type II - Google Patents

Anvendelse af tetrahydrolipstatin i behandling af diabetes type II

Info

Publication number
DK1017408T3
DK1017408T3 DK98908008T DK98908008T DK1017408T3 DK 1017408 T3 DK1017408 T3 DK 1017408T3 DK 98908008 T DK98908008 T DK 98908008T DK 98908008 T DK98908008 T DK 98908008T DK 1017408 T3 DK1017408 T3 DK 1017408T3
Authority
DK
Denmark
Prior art keywords
tetrahydrolipstatin
diabetes
treatment
type
Prior art date
Application number
DK98908008T
Other languages
Danish (da)
English (en)
Inventor
Jonathan Brian Hauptman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1017408(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1017408T3 publication Critical patent/DK1017408T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98908008T 1997-02-05 1998-01-29 Anvendelse af tetrahydrolipstatin i behandling af diabetes type II DK1017408T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
EP98908008A EP1017408B1 (en) 1997-02-05 1998-01-29 Use of tethrahydrolipstatin in the treatment of diabetes type ii
PCT/EP1998/000468 WO1998034630A1 (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Publications (1)

Publication Number Publication Date
DK1017408T3 true DK1017408T3 (da) 2005-08-01

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98908008T DK1017408T3 (da) 1997-02-05 1998-01-29 Anvendelse af tetrahydrolipstatin i behandling af diabetes type II

Country Status (28)

Country Link
US (1) US6147108A (xx)
EP (1) EP1017408B1 (xx)
JP (1) JP2001509173A (xx)
KR (1) KR100479968B1 (xx)
CN (1) CN1154505C (xx)
AR (1) AR011106A1 (xx)
AT (1) ATE292975T1 (xx)
AU (1) AU740375B2 (xx)
BR (1) BR9807655A (xx)
CA (1) CA2278854C (xx)
CZ (1) CZ295567B6 (xx)
DE (1) DE69829763T2 (xx)
DK (1) DK1017408T3 (xx)
ES (1) ES2239799T3 (xx)
HK (1) HK1025251A1 (xx)
HU (1) HU230834B1 (xx)
ID (1) ID22650A (xx)
IL (1) IL131007A0 (xx)
ME (1) ME00578A (xx)
NO (1) NO324452B1 (xx)
NZ (1) NZ336755A (xx)
PL (1) PL191222B1 (xx)
PT (1) PT1017408E (xx)
RU (1) RU2201272C2 (xx)
TR (1) TR199901853T2 (xx)
WO (1) WO1998034630A1 (xx)
YU (1) YU34199A (xx)
ZA (1) ZA98753B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2278854C (en) * 1997-02-05 2014-03-04 F. Hoffmann-La Roche Ag Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin for treating type ii diabetes
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
ES2324280T3 (es) 2000-03-14 2009-08-04 Unilever N.V. Dominios variables de la cadena pesada de anticuerpos frente a lipasas dieteticas humanas y sus usos.
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US9174176B2 (en) * 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
CA2580313C (en) 2004-07-19 2016-03-15 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8036727B2 (en) * 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
AU2006235535A1 (en) 2005-04-13 2006-10-19 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
PL2036575T3 (pl) * 2007-09-12 2011-02-28 Mader S R L Kompozycje farmaceutyczne do stosowania doustnie w leczeniu pacjentów dotkniętych otyłością
US20100317642A1 (en) * 2007-10-15 2010-12-16 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
CN101939023B (zh) 2007-10-16 2016-08-03 百康有限公司 可经口给药的固体药物组合物及其方法
US8571617B2 (en) 2008-03-04 2013-10-29 Glt Acquisition Corp. Flowometry in optical coherence tomography for analyte level estimation
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
JP2019515654A (ja) * 2016-03-16 2019-06-13 ザ ジェイ． デヴィッド グラッドストーン インスティテューツ 肥満及び／又は糖尿病を処置するための方法及び組成物、並びに候補処置薬剤を識別するための方法及び組成物
US20190022061A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang Statins (Atorvastatin) can lower blood sugar level in diabetic

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
CA2278854C (en) * 1997-02-05 2014-03-04 F. Hoffmann-La Roche Ag Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin for treating type ii diabetes

Also Published As

Publication number Publication date
CZ295567B6 (cs) 2005-08-17
CA2278854A1 (en) 1998-08-13
WO1998034630A1 (en) 1998-08-13
KR100479968B1 (ko) 2005-03-30
HUP0001014A2 (hu) 2000-08-28
ES2239799T3 (es) 2005-10-01
DE69829763D1 (de) 2005-05-19
HU230834B1 (hu) 2018-07-30
AU6616998A (en) 1998-08-26
RU2201272C2 (ru) 2003-03-27
HUP0001014A3 (en) 2000-12-28
CN1246798A (zh) 2000-03-08
NO993717D0 (no) 1999-07-30
PL191222B1 (pl) 2006-03-31
PL334975A1 (en) 2000-03-27
PT1017408E (pt) 2005-07-29
NO324452B1 (no) 2007-10-22
JP2001509173A (ja) 2001-07-10
NO993717L (no) 1999-10-04
US6147108A (en) 2000-11-14
TR199901853T2 (xx) 1999-12-21
EP1017408B1 (en) 2005-04-13
DE69829763T2 (de) 2006-04-13
ID22650A (id) 1999-12-02
ZA98753B (en) 1998-08-05
NZ336755A (en) 2001-06-29
CN1154505C (zh) 2004-06-23
KR20000070733A (ko) 2000-11-25
BR9807655A (pt) 2000-02-15
ME00578A (en) 2011-12-20
AR011106A1 (es) 2000-08-02
CZ265199A3 (cs) 2000-02-16
AU740375B2 (en) 2001-11-01
IL131007A0 (en) 2001-01-28
ATE292975T1 (de) 2005-04-15
YU34199A (sh) 2002-08-12
CA2278854C (en) 2014-03-04
EP1017408A1 (en) 2000-07-12
HK1025251A1 (en) 2000-11-10

Similar Documents

Publication Publication Date Title
DK1017408T3 (da) Anvendelse af tetrahydrolipstatin i behandling af diabetes type II
DE59709443D1 (de) Blutpumpe
NO2006014I1 (no) Insulin glulisin
DE69822059D1 (de) Wegwerfwindel
DE69828931D1 (de) Wegwerfwindel
DE69431204D1 (de) Blutpumpe
DE69826619D1 (de) Wegwerfwindel
ID17315A (id) Perekat yang dapat digabungkan secara hayati
DE69825982D1 (de) Spritze
NO983266D0 (no) Distribuert Behandling
DE69817446D1 (de) Behandlung von diabetes
DE69736579D1 (de) Faltbare Wegwerfwindel
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
DK0745396T3 (da) Blodpumpe og anvendelse deraf
DE69821187D1 (de) Wegwerfwindel
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
DE69812588D1 (de) Medizinischer injektor
ID15967A (id) Agen terapi diabetes
DE69807225D1 (de) Vliesstoffbehandlung
DK0903130T4 (da) Forbedringer i forbindelse med ostomiindretninger
DE59810482D1 (de) Schleifen von garnituren
NO983263D0 (no) Distribuert behandling
FI974244A0 (fi) Foerfarande foer kompressering av en bild
DE69820586D1 (de) Oszillator
NO995492D0 (no) Algicider